Eric Bartee

9PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionElectrical energy storageMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 25, 2025
Constructing the cure: engineering the next wave of antibody and cellular immune therapies.

Stefanie R Bailey, Eric Bartee, Kyle G Daniels

|Jun 03, 2023
Defects in intratumoral arginine metabolism attenuate the replication and therapeutic efficacy of oncolytic myxoma virus.

Parker Dryja, Heather D Curtsinger, Mee Y Bartee

|Jan 05, 2023
High Levels of Extracellular Potassium Can Delay Myxoma Virus Replication by Preventing Release of Virions from the Endosomes.

Heather D Curtsinger, Xianyi Zeng, Zaira Mather

|May 16, 2022
TNF blockade enhances the efficacy of myxoma virus-based oncolytic virotherapy.

Miriam Valenzuela-Cardenas, Cody Gowan, Parker Dryja

|Apr 13, 2022
The use of oncolytic virotherapy in the neoadjuvant setting.

Raquela J Thomas, Eric Bartee

|Jan 12, 2022
B cells imprint adoptively transferred CD8<sup>+</sup> T cells with enhanced tumor immunity.

Aubrey S Smith, Hannah M Knochelmann, Megan M Wyatt

Pageof 2

Frequent Collaborators

1 joint publications

Aubrey S Smith

1 joint publications

Pravin Kaumaya

1 joint publications

Gregory B Lesinski

1 joint publications

Megen C Wittling